Literature DB >> 12596048

Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis.

Mitsuteru Akahoshi1, Hitoshi Nakashima, Katsuhisa Miyake, Yasushi Inoue, Sakiko Shimizu, Yosuke Tanaka, Kaoru Okada, Takeshi Otsuka, Mine Harada.   

Abstract

Host genetic factors may be important determinants of susceptibility to tuberculosis, and several candidate gene polymorphisms have been shown to date. A series of recent reports concerning rare human deficiencies in the type-1 cytokine pathway suggest that more subtle variants of relevant genes may also contribute to susceptibility to tuberculosis at the general population level. To investigate whether polymorphisms in the interleukin-12 receptor (IL-12R) gene predispose individuals to tuberculosis, we studied these genes by single-strand conformational polymorphism analysis and direct sequencing. Although no common polymorphisms could be identified in the IL-12R beta 2 gene ( IL-12RB2), we confirmed four single nucleotide polymorphisms (SNPs; 641A-->G, 684C-->T, 1094T-->C, and 1132G-->C) causing three missense variants (Q214R, M365T, G378R) and one synonymous substitution in the extracellular domain of the IL-12R beta 1 gene ( IL12RB1). All SNPs were in almost perfect linkage disequilibrium (D'=0.98), and two common haplotypes of IL12RB1(allele 1: Q214-M365-G378; allele 2: R214-T365-R378) were revealed. Polymerase chain reaction/restriction fragment length polymorphism and sequence analyses were used to type IL12RB1polymorphisms in 98 patients with tuberculosis and 197 healthy controls in Japanese populations. In our case-control association study of tuberculosis, the R214-T365-R378 allele (allele 2) was over-represented in patients with tuberculosis, and homozygosity for R214-T365-R378 (the 2/2 genotype) was significantly associated with tuberculosis (odds ratio: 2.45; 95% CI: 1.20-4.99; P=0.013). In healthy subjects, homozygotes for R214-T365-R378 had lower levels of IL-12-induced signaling, according to differences in cellular responses to IL-12 between two haplotypes. These data suggest that the R214-T365-R378 allele, i.e., variation in IL12RB1, contribute to tuberculosis susceptibility in the Japanese population. This genetic variation may predispose individuals to tuberculosis infection by diminishing receptor responsiveness to IL-12 and to IL-23, leading to partial dysfunction of interferon-gamma-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12596048     DOI: 10.1007/s00439-002-0873-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples.

Authors:  S Marquet; E Schurr
Journal:  Drug Metab Dispos       Date:  2001-04       Impact factor: 3.922

Review 2.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Authors:  Tom H M Ottenhoff; Frank A W Verreck; Elgin G R Lichtenauer-Kaligis; Marieke A Hoeve; Ozden Sanal; Jaap T van Dissel
Journal:  Nat Genet       Date:  2002-09       Impact factor: 38.330

3.  Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor.

Authors:  C Wu; J Ferrante; M K Gately; J Magram
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

Review 4.  IL12 receptors and receptor antagonists.

Authors:  D H Presky; U Gubler; R A Chizzonite; M K Gately
Journal:  Res Immunol       Date:  1995 Sep-Oct

Review 5.  The immunogenetics of human infectious diseases.

Authors:  A V Hill
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection.

Authors:  Houda Elloumi-Zghal; Mohamed Ridha Barbouche; Jalel Chemli; Mohamed Béjaoui; Abdelaziz Harbi; Noureddine Snoussi; Sonia Abdelhak; Koussay Dellagi
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

7.  Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency.

Authors:  G Aksu; C Tirpan; C Cavuşoğlu; S Soydan; F Altare; J L Casanova; N Kutukculer
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

8.  Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis.

Authors:  F Altare; A Ensser; A Breiman; J Reichenbach; J E Baghdadi; A Fischer; J F Emile; J L Gaillard; E Meinl; J L Casanova
Journal:  J Infect Dis       Date:  2001-06-14       Impact factor: 5.226

9.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

10.  Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective.

Authors:  P E Fine
Journal:  Int J Lepr Other Mycobact Dis       Date:  1981-12
View more
  28 in total

Review 1.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

2.  Personalized medicine approach in mycobacterial disease.

Authors:  Mehdi Mirsaeidi
Journal:  Int J Mycobacteriol       Date:  2012-06

3.  IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination.

Authors:  Radha Gopal; Yinyao Lin; Nataša Obermajer; Samantha Slight; Nikhil Nuthalapati; Mushtaq Ahmed; Pawel Kalinski; Shabaana A Khader
Journal:  Eur J Immunol       Date:  2011-12-20       Impact factor: 5.532

4.  Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages.

Authors:  Halli E Miller; Richard T Robinson
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

5.  Tuberculosis Infection: Insight from Immunogenomics.

Authors:  Matthew Arentz; Thomas R Hawn
Journal:  Drug Discov Today Dis Mech       Date:  2007

6.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

7.  Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.

Authors:  Tony Hawkridge; Thomas J Scriba; Sebastian Gelderbloem; Erica Smit; Michele Tameris; Sizulu Moyo; Trudie Lang; Ashley Veldsman; Mark Hatherill; Linda van der Merwe; Helen A Fletcher; Hassan Mahomed; Adrian V S Hill; Willem A Hanekom; Gregory D Hussey; Helen McShane
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

8.  Association between IFNA genotype and the risk of sarcoidosis.

Authors:  Mitsuteru Akahoshi; Mami Ishihara; Natascha Remus; Kazuko Uno; Katsuhisa Miyake; Tomomitsu Hirota; Kazuko Nakashima; Akira Matsuda; Mizuo Kanda; Tadao Enomoto; Shigeaki Ohno; Hitoshi Nakashima; Jean-Laurent Casanova; Julian M Hopkin; Mayumi Tamari; Xiao-Quan Mao; Taro Shirakawa
Journal:  Hum Genet       Date:  2004-03-05       Impact factor: 4.132

9.  Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Denise A Galloway; Janet R Daling; Mari Malkki; Effie W Petersdorf; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

Review 10.  IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database.

Authors:  Esther van de Vosse; Margje H Haverkamp; Noe Ramirez-Alejo; Mónica Martinez-Gallo; Lizbeth Blancas-Galicia; Ayşe Metin; Ben Zion Garty; Çağman Sun-Tan; Arnon Broides; Roelof A de Paus; Özlem Keskin; Deniz Çağdaş; Ilhan Tezcan; Encarna Lopez-Ruzafa; Juan I Aróstegui; Jacov Levy; Francisco J Espinosa-Rosales; Özden Sanal; Leopoldo Santos-Argumedo; Jean-Laurent Casanova; Stephanie Boisson-Dupuis; Jaap T van Dissel; Jacinta Bustamante
Journal:  Hum Mutat       Date:  2013-08-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.